Vaccine-Preventable Diseases

Top Story

CDC: Yellow fever vaccine supply to be depleted in US by mid-2017

April 28, 2017

Read the Perspective from Rebecca Katz, PhD, MPH

The CDC announced today that it is anticipating a complete depletion of the U.S. supply of YF-VAX — the only yellow fever vaccine licensed in the United States — by mid-2017.

In response, the CDC is collaborating with the vaccine’s manufacturer, Sanofi Pasteur, to distribute limited quantities of another yellow fever vaccine, Stamaril (Sanofi Pasteur France), that is not licensed in the U.S. However, the number of sites that will offer the vaccine will be significantly less than the number of sites that usually distribute YF-VAX.

US- and foreign-born teens show comparable vaccination rates

April 28, 2017
ATLANTA — Teenagers who were born in a country other than the United States were shown to have comparable vaccination coverage rates when compared with U.S.-born
Meeting News Coverage

Pertussis incidence highest among infants younger than 2 months

April 27, 2017
ATLANTA — Research presented at the 2017 Epidemic Intelligence Service Conference demonstrates that the age group most severely affected by pertussis are infants
Meeting News

Haiti still prone to cholera despite increased access to improved water sources

April 27, 2017
ATLANTA — More than 7 years after a 7.0-magnitude earthquake set the stage for a cholera outbreak in Haiti, people in the resource-poor West Indies nation are…
CME

Vaccine-Preventable Outbreaks: Still with Us After All These Years

Pediatric Annals, April 2015, Volume 44 Issue 4
Outbreaks of vaccine-preventable diseases continue to occur in the United States, and they have been occurring at…
More »
CME

Vaccines: April 2015

Keck School of Medicine of USC and Pediatric Annals

Vaccine refusal and hesitancy to vaccinate has been a growing problem in the past 2-3 decades. Perhaps victims of our…
More »
Featured
American Academy of Allergy, Asthma & Immunology Annual Meeting

American Academy of Allergy, Asthma & Immunology Annual Meeting

Video
Meeting News Coverage

Measles and rubella eliminated in the Americas; more work needed for global elimination

December 8, 2015
More »

WHO gains funds needed to launch pilot implementation of malaria vaccine

November 20, 2016
A $15 million grant from The Global Fund to Fight AIDS, Tuberculosis and Malaria will go toward a project that allows WHO and its partners to…

In the Journals

Delaying Gardasil uptake, completion incurs infection, abnormalities

November 18, 2016
Delayed uptake and longer times between doses of HPV vaccine accrued increased rates of infection and cervical cytological abnormalities, per data…

In the Journals

Decline in pulmonary TB hospitalizations among children not associated with PCV

November 16, 2016
Researchers in South Africa found no temporal association between hospitalizations for children with culture-confirmed pulmonary tuberculosis and…

Feature

DNA-based Zika vaccine development continues after promising early data

November 10, 2016
PHILADELPHIA – The Wistar Institute recently hosted a Q&A discussion panel event during which researchers shared promising new developments…

In the Journals

Triggered vaccination campaigns could reduce size, severity of measles outbreaks

November 8, 2016
Supplemental vaccination campaigns triggered by measles outbreaks could significantly reduce incidence and prevent more severe outbreaks, with…

Apnea/bradycardia non-recurrent with DTwP vaccine in low-birth-weight infants

November 4, 2016
NEW ORLEANS – Immunization with diphtheria, tetanus and whole cell pertussis did not increase or cause recurrence risk for apnea/bradycardia in…

Search for RSV vaccine includes new target

November 4, 2016
A vaccine for respiratory syncytial virus, or RSV, has long remained out of reach for researchers, but a drug that takes aim at a novel target has…

Meeting NewsVideo

VIDEO: Researchers make progress in norovirus vaccine development

October 30, 2016
NEW ORLEANS — John J. Treanor, MD, chief of infectious diseases at the University of Rochester Medical Center, reviews several vaccine…

Meeting News

Fatal measles complication more common than previously understood

October 28, 2016
NEW ORLEANS — Subacute sclerosing panencephalitis — a 100% fatal complication of measles — occurs much more often than previously…

Meeting News

Priorix, M-M-R II exhibited similar safety, immune response during MMR vaccination

October 28, 2016
NEW ORLEANS – A measles, mumps and rubella vaccine developed by GlaxoSmithKline to have immune response rates and a safety profile similar to…

More Headlines »
Advertisement
Advertisement